Syria seizes drugs destined for Saudi Arabia
Syria: Sunday, February 10 - 2008 at 12:50
Syrian customs authorities have seized hundreds of thousands of smuggled stimulant pills bound for Saudi Arabia, reported AP.More than 400,000 pills of the amphetamine-like drug Captagon hidden in bathroom tissue rolls were seized last month at a shipping company office in the northern city of Aleppo.The pills were bound for Saudi Arabia and a Syrian man from Aleppo who was involved was later arrested in the Syrian port city of Latakia. Captagon, also known as fenethylline, was listed by World Health Organization in 1986 as a pyschotropic substance, and is banned in most places and was once prescribed as an antidepressant or to treat hyperactive children.
Readers' recommendation
This story is currently rated 5.93 of 10 based on 14 readers' recommendations
This story is currently rated 5.93 of 10 based on 14 readers' recommendations
Also consider reading:
- » Thailand to train 3,000 nurses for Bahrain
- » Yemen improperly disposes 57 tons of medical waste each day
- » Heaters hit sales in Sharjah
- » Dr Moopen's Group to invest in Oman
- » HIV males in Egypt face arrest, torture
- » Yemen, Italy talk over health cooperation
- » Magrabi Hospitals expand in Egypt and Yemen
- » Egg-freezing service for UAE women
- » Qatar pulls some bottled water off shelves
- » Healthcare cooperation between Turkey and Kuwait
Amena Bakr, Senior ReporterSunday, February 10 - 2008 at 12:50 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Index : Healthcare
Browse related articles
Browse related articlesToday's most read articles:
Most read articles the past week:
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.



Web Feeds